Company intelligence / Profile preview

CHOLLEY

Lugano, Ticino, Switzerland

Ownership: Private
Development stage: Other

Overview

CHOLLEY offers cosmeceuticals with clinical and dermatological testing supporting efficacy in anti-aging, skin repair, brightening, and revitalizing. Their proprietary IC-RAMP® and PHYTOBIOTECH® technologies are used in products clinically validated for skin health and protection with measurable cosmetic results.

Therapeutic areas: Dermatology
Modalities: Plant stem cell extractBotanical extractBiologic
Industry: Non-Drug Biotech

Partnerships

Collaborations with Swiss academic centers (not named specifically)[7]

Beyond the preview

Go deeper on CHOLLEY.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHOLLEY.

Explore the full profile